Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain Modulation in RA - Influence of Adalimumab. A Randomized, Placebo-controlled Study Using Functional Magnetic Resonance Imaging (PARADE)

NCT01197144 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT01197144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01197144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain Modulation in RA - Influence of Adalimumab. A Randomized, Placebo-controlled Study Using Functional Magnetic Resonance Imaging (PARADE)
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
November 28, 2016
Enrollment
70 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid, fatigue, pain